A new medium selective for Bacteroides gracilis was developed. The medium is tryptic soy agar (Difco Laboratories, Detroit, Mich.) containing nalidixic acid, teicoplanin, sodium formate, sodium fumarate, and potassium nitrate. Ail 18 strains of B. gracilis tested grew with only minimal inhibition. Most of the other 214 organisms tested, including most Bacteroides species, other anaerobes, and a substantial number of facultative anaerobes, were significantly inhibited by the medium. In a diagnostic study of 49 clinical specimens (28 patients with intra-abdominal infection, mostly gangrenous or perforated appendicitis), four strains of B. gracilis were isolated (from 4 different patients) on B. gracilis selective agar but were not detected on standard media.
Bacteroides gracilis is an obligately anaerobic gram-negative, asaccharolytic, nonmotile, agar-pitting bacillus found in oral and dental infections, brain abscesses, pulmonary infections, peritonitis, intra-abdominal abscesses, wound infections, and soft tissue abscesses (10, 14) . Since B. gracilis has been recovered primarily from polymicrobial infections (9) , the pathogenic potential of this organism itself remains uncertain. The frequency of association of this species with serious anaerobic infections, however, implies virulence; moreover, many I-lactam and other drugs have relatively poor in vitro activity against B. gracilis (10) . The organism grows slowly and forms small, translucent colonies and therefore can easily be overlooked in mixed cultures; for this reason, development of a selective medium for specific recovery of B. gracilis would be of particular value. We have developed such a medium, designated B. gracilis selective agar (BGSA). It contains tryptic soy agar base, formate, fumarate, nitrate, and two selective agents, nalidixic acid and teicoplanin.
MATERIALS AND METHODS
Bacterial strains. Two hundred thirty-two strains of bacteria were used in this study (Tables 1 and 2 ). These included 18 strains of B. gracilis; 112 strains of other anaerobic, gram-negative rods; 11 strains of anaerobic, gram-negative cocci; 10 strains of anaerobic gram-positive cocci, 14 strains of anaerobic, gram-positive rods; and 67 strains of various aerobic or facultative bacteria. All anaerobic isolates, except the reference strain of B. gracilis (ATCC 33236), were from the Wadsworth Anaerobic Bacteriology Laboratory collection and were kept frozen in 20% skim milk at -70°C until use. These organisms had been identified by the methods outlined in the Virginia Polytechnic Institute and Wadsworth anaerobic laboratory manuals (7, 13 (9) subsequently reported that B. gracilis was recovered from patients with serious visceral or head and neck infections, whereas a similar organism, B. ureolyticus, was isolated primarily from superficial skin and soft tissue infections (survey of specimens studied over a period of 11 years). B. gracilis showed a relatively high incidence of antibiotic resistance (10) .
Tryptic soy agar was chosen as the base medium for BGSA on the basis of a comparison with other media, including Mueller-Hinton and brain heart infusion agars (data not shown). The medium does not contain sheep blood, which is not required for growth of B. gracilis, but does enhance the growth of most other anaerobes. Growth of all strains of B. gracilis requires formate and fumarate, and some of them use nitrate as an electron acceptor (14) .
Several other investigators have used crystal violet, bacitracin, vancomycin, and teicoplanin for inhibition of grampositive organisms (5, 8, 12, 15) . Recently, Greenwood et al. (Tables 1 and 2 ) but showed little activity against B. gracilis. This effect was increased by using media lacking blood. The inhibitory activity of teicoplanin was stronger than those of bacitracin and vancomycin. Nalidixic acid is commonly used to inhibit aerobic and facultatively anaerobic, gram-negative bacteria for selective media (3, 4) . Nalidixic acid at 8 mg/liter in BGSA did not completely inhibit facultative organisms but did suppress most of those strains ( (1) , an organism which Lee et al. (3) describe as being similar to B.
gracilis.
We would like to make it clear to your readers that the medium developed for B. ureolyticus contained nalidixic acid (10 mg/liter), despite the fact that Lee et al. (3) only refer to its containing teicoplanin (20 mg/liter). Although we were pleased to see that these selective agents were not inhibitory to the growth of 18 strains of B. gracilis, the results were hardly surprising to us, as B. gracilis ATCC 33236 was used as a control in the routine assessment of differential activity of our medium, which also included urea. Rather than choosing tryptic soy agar as a basal medium, we used fastidious anaerobe agar, which has been shown to be excellent for the growth of fastidious anaerobic bacteria (2) . Fastidious anaerobe agar is much more complex than tryptic soy agar, even though it does not incorporate potassium nitrate, a supplement added by Lee et al. (3) . However, to date there have been no studies which show enhancement of growth by nitrate in the presence of formate and fumarate. We also supplemented fastidious anaerobe agar with an additional amount of agar, making a total of 22 g/liter (compared with 15 g/liter in tryptic soy agar), which can be useful in reducing the swarming of Proteus spp., bacteria known to grow on both selective media.
A problem with the medium described by Lee et al. (3) was the difficulty in distinguishing between B. gracilis and other organisms isolated from clinical specimens. This difficulty might be partly overcome by the incorporation of, for example, urea, which would make it possible to identify urease-producing organisms. This would mean that time and reagents would not be wasted on the identification of isolates which are obviously not B. gracilis, which is urease negative. Such a modification would add a dimension to the selective medium for B. gracilis and ultimately make it of greater use in diagnostic microbiology.
